Gain Therapeutics (GANX) analyst forecast and price target
Analyst forecast
Consensus of 5 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $8.00 | Aug 31, 2026 |
| BTIG | Maintained | Buy | $5.00 | Aug 11, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | Jul 1, 2026 |
| BTIG | Maintained | Buy | $5.00 | Jun 30, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | Dec 19, 2025 |
| BTIG | Maintained | Buy | $9.00 | Oct 15, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | Oct 13, 2025 |
| Maxim Group | Maintained | Buy | $7.00 from $5.00 | Oct 7, 2025 |
| BTIG | Maintained | Buy | $9.00 | Sep 8, 2025 |
| Roth Capital | Maintained | Buy | $6.00 from $7.00 | Aug 13, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | Jul 3, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | May 19, 2025 |
| Chardan Capital | Maintained | Buy | $6.00 | Mar 28, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | Mar 17, 2025 |
| Scotiabank | Initiated Coverage | Sector Outperform | $12.00 | Mar 7, 2025 |
| Roth MKM | Maintained | Buy | $7.00 | Dec 24, 2024 |
| Roth MKM | Initiated Coverage | Buy | $7.00 | Dec 5, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | Nov 25, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | Oct 9, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | Oct 1, 2024 |
Frequently asked questions
Is GANX a buy, sell, or hold?
Analysts covering Gain Therapeutics currently average a Buy rating: 5 buy, 0 hold and 0 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on GANX?
On Aug 31, 2026, HC Wainwright & Co. maintained Gain Therapeutics at Buy with a price target of $8.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.